(USD) | Sep 2023 | Q/Q |
---|---|---|
Revenue | 383.6MM | +32% |
Gross Profit | 248.2MM | +15% |
Cost Of Revenue | 135.4MM | +77% |
Operating Income | 404K | -99% |
Operating Expenses | 247.8MM | +66% |
Net Income | 998K | -98% |
R&D | 29.3MM | +37% |
G&A | 156.2MM | +30% |
Amortization | 13.8MM | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes. I think that investing in robotic surgery stocks is an underrated thematic choice for investors. The reason being is that there is currently a very low industry penetration of using robots in the surgical market, which means ther
Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globus Medical ( NYSE:GMED ) Full Year 2023 Results Key Financial Results Revenue: US$1.57b (up 53% from FY 2022). Net...
In this piece, we will take a look at the 11 best small-cap growth stocks to invest in. If you want to skip our primer about the benefits and drawbacks of investing in small cap stocks, then you can take a look at the 5 Best Small-Cap Growth Stocks to Invest In. The small cap […]
Q4 2023 Globus Medical Inc Earnings Call
Globus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Call Transcript February 20, 2024 Globus Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the Globus Medical’s Fourth Quarter and Full Year 2023 […]